Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Bernard

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
European Journal of Medicinal Chemistry|July 28, 2014
New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysisSandrine Grosse, Véronique Mathieu, Christelle Pillard, et al.
The Journal of Allergy and Clinical Immunology|September 18, 2016
Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytesMeriem Riani, Sébastien Le Jan, Julie Plée, et al.
Planta Medica|September 14, 2007
Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzinQuoc-Tuan Do, Cécile Lamy, Isabelle Renimel, et al.
Archives of Dermatology|March 23, 2011
Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patientsJulie Charneux, Johanna Lorin, Fabien Vitry, et al.
Frontiers in Immunology|April 18, 2018
Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 AutoantibodyAriane Clapé, Céline Muller, Grégory Gatouillat, et al.
European Journal of Dermatology : EJD|November 15, 2006
P16 is overexpressed in cutaneous carcinomas located on sun-exposed areasIsabelle Conscience, Nicolas Jovenin, Christelle Coissard, et al.
Journal of Medicinal Chemistry|September 12, 2009
Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studiesAurélien Putey, Florence Popowycz, Quoc-Tuan Do, et al.
Clinical Pharmacology and Therapeutics|September 8, 2022
Population PK and Semimechanistic PK/PD Modeling and Simulation of Relugolix Effects on Testosterone Suppression in Men with Prostate CancerTien-Yi Lee, Philippe Bernard Pierrillas, Yu-Wei Lin, et al.
Journal of Neurochemistry|April 16, 2003
Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding propertiesBrigitte Ilien, Christelle Franchet, Philippe Bernard, et al.
The Journal of Investigative Dermatology|November 26, 2002
Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomainSilkeC Hofmann, Sybille Thoma-Uszynski, Thomas Hunziker, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
European Journal of Medicinal Chemistry|July 28, 2014
New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysisSandrine Grosse, Véronique Mathieu, Christelle Pillard, et al.
The Journal of Allergy and Clinical Immunology|September 18, 2016
Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytesMeriem Riani, Sébastien Le Jan, Julie Plée, et al.
Planta Medica|September 14, 2007
Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzinQuoc-Tuan Do, Cécile Lamy, Isabelle Renimel, et al.
Archives of Dermatology|March 23, 2011
Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patientsJulie Charneux, Johanna Lorin, Fabien Vitry, et al.
Frontiers in Immunology|April 18, 2018
Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 AutoantibodyAriane Clapé, Céline Muller, Grégory Gatouillat, et al.
European Journal of Dermatology : EJD|November 15, 2006
P16 is overexpressed in cutaneous carcinomas located on sun-exposed areasIsabelle Conscience, Nicolas Jovenin, Christelle Coissard, et al.
Journal of Medicinal Chemistry|September 12, 2009
Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studiesAurélien Putey, Florence Popowycz, Quoc-Tuan Do, et al.
Clinical Pharmacology and Therapeutics|September 8, 2022
Population PK and Semimechanistic PK/PD Modeling and Simulation of Relugolix Effects on Testosterone Suppression in Men with Prostate CancerTien-Yi Lee, Philippe Bernard Pierrillas, Yu-Wei Lin, et al.
Journal of Neurochemistry|April 16, 2003
Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding propertiesBrigitte Ilien, Christelle Franchet, Philippe Bernard, et al.
The Journal of Investigative Dermatology|November 26, 2002
Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomainSilkeC Hofmann, Sybille Thoma-Uszynski, Thomas Hunziker, et al.
Pageof 14